BHC - Bausch Health Companies Inc.
5.38
-0.190 -3.532%
Share volume: 1,757,196
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$5.57
-0.19
-0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-20-2025 | 04-30-2025 | 07-30-2025 | 10-29-2025 | 02-18-2026 | |
| Total revenue | 2.559 B | 2.259 B | 2.530 B | 2.681 B | 2.796 B | |
| Cost of revenue | 727.000 M | 701.000 M | 764.000 M | 750.000 M | 798.000 M | |
| Gross profit | 1.832 B | 1.558 B | 1.766 B | 1.931 B | 1.998 B | |
| -14.96% | 13.35% | 9.34% | 3.47% | |||
| Operating expenses | 983.000 M | 1.010 B | 1.053 B | 961.000 M | 1.043 B | |
| Selling general and admin | 820.000 M | 867.000 M | 894.000 M | 795.000 M | 882.000 M | |
| Research and development | 163.000 M | 143.000 M | 159.000 M | 166.000 M | 161.000 M | |
| Total expenses | 1.274 B | 1.282 B | 1.322 B | 1.312 B | 1.524 B | |
| 0.63% | 3.12% | -0.76% | 16.16% | |||
| Operating income | 558.000 M | 276.000 M | 444.000 M | 619.000 M | 474.000 M | |
| Ebit | 537.000 M | 272.000 M | 414.000 M | 612.000 M | 463.000 M | |
| Pretax income | 209.000 M | -47.000 M | 140.000 M | 218.000 M | 56.000 M | |
| -122.49% | -397.87% | 55.71% | -74.31% | |||
| Income tax | 111.000 M | 39.000 M | 12.000 M | 37.000 M | 159.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 98.000 M | -86.000 M | 128.000 M | 181.000 M | -103.000 M | |
| -187.76% | 248.84% | 41.41% | -156.91% |